HOME >> MEDICINE >> NEWS
Implanted defibrillators cut heart patients death risk, some more than others

NEW ORLEANS -- Implanted devices that can shock a failing heart back into regular rhythm do an excellent job of keeping patients alive, two new University of Michigan studies find.

The research also suggests that doctors may be able to categorize their patients according to their individual risk factors, to determine who might get the largest benefit from the expensive devices, called implanted cardiac defibrillators, or ICDs. The studies also reinforce the importance of providing good follow-up care to all heart failure patients, whether or not they receive an implanted device.

With Medicare poised to start covering ICDs for many more patients than ever before, the new results come just in time to help doctors decide which patients might get the greatest benefit from the costly devices. More than half a million more people may qualify for ICDs, which cost around $20,000, under Medicare guidelines that will take effect soon.

The data were presented here today in two talks at the Scientific Sessions of the American Heart Association by a U-M Cardiovascular Center team that analyzed data from 7,000 veterans treated for heart trouble in Veterans Affairs hospitals between 1995 and 1999. All had congestive heart failure, heart muscle damage caused by clogged blood vessels, and a heart rhythm irregularity called ventricular arrhythmia. Of the 7,000 patients, 1,442 had received an ICD.

The researchers found that those who received an ICD were 60 percent less likely to die in the next year, and 48 percent less likely to die in three years, than those who did not receive an ICD. Most of this reduction in death risk was due to reduction in heart-related deaths. ICDs are specifically designed to prevent sudden cardiac death, in which the heart's electrical system goes haywire, causing it to stop beating.

But ICD recipients who had co-existing medical conditions, especially diabetes or kidney failure, were much more likely to
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
8-Nov-2004


Page: 1 2 3 4

Related medicine news :

1. Implanted devices detect high-risk heart failure patients
2. Implanted defibrillators not covered for half of patients who could benefit, study finds
3. Implanted stimulator for Parkinsons disease impairs cognitive function
4. Implanted defibrillators and anti-theft systems appear safe under normal circumstances
5. Implantable heart defibrillators
6. More doubts over value of defibrillators
7. One use every seven years makes automated external defibrillators a good buy
8. Benefit of public defibrillators is marginal
9. Implantable defibrillators cost-effective for preventing sudden death
10. Health and fitness facilities need defibrillators
11. New study in Nature demonstrates protection against cell death during heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Health & Safety Institute ... and HAZWOPER 8-, 24- and 40-Hour courses from now until November 30, 2017 to ... to offering these discounted prices to all businesses and government agencies – whether or ...
(Date:9/20/2017)... ... 2017 , ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in ... 11, off work and rolled up their sleeves to help with relief efforts. The ... start the process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment ...
(Date:9/20/2017)... ... September 20, 2017 , ... “They Sang At Her Funeral”: a tale ... starts revealing the skeletons in their closets. “They Sang At Her Funeral” is the ... years young and married with five children and twelve grandchildren. Before becoming a writer, ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... on St. Vincent’s Infusion Services called, “PAPA Healthcare helps fill gaps, provide essential ... Services enhanced service delivery and operations by leveraging PAPA Healthcare’s post-acute productivity and ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... the winners of the Entrepreneur Innovation Awards (EIA), held this past Thursday night ... are Connecticut-based companies and entrepreneurs, presented their innovative project ideas to a panel ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017 NuvoAir (formerly called ... announced today a partnership with Novartis Pharma AG to distribute ... position as the leading mobile spirometry platform and Novartis, commitment ... ... ...
(Date:9/6/2017)... Sept. 6, 2017  Robert G. Szewc, M.D., is ... Member in recognition of his contributions to the Medical ... a Nephrologist at the practice of Kidney and Hypertension ... care and hypertension solutions. He has worked in this ... career experience, as well as expertise in kidneys, hypertension, ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology:
Cached News: